US officials plan to release 6.4 million COVID-19 vaccine doses in first distribution
>> Reuters
Published: 25 Nov 2020 08:48 AM BdST Updated: 25 Nov 2020 08:48 AM BdST
-
Vials of coronavirus disease (COVID-19) vaccine candidate BNT162b2 are inspected at a Pfizer manufacturing site in Kalamazoo, Michigan, US in an undated photograph. Pfizer handout via REUTERS
US officials said on Tuesday they plan to release 6.4 million COVID-19 vaccine doses nationwide in an initial distribution after the first one is cleared by regulators for emergency use.
Officials from the government’s Operation Warp Speed programme told reporters that states and other jurisdictions had been informed on Friday of their estimated vaccine allocations in the first shipments so they can begin planning for how to best distribute it to their high-risk populations.
The officials had previously said they anticipate 40 million doses will be distributed by year end, a number they reiterated on Tuesday.
Pfizer Inc last week filed for the first US emergency use authorisation (EUA) of a COVID-19 vaccine after releasing data that showed it was 95% effective at preventing the illness in a large, Phase III trial.
The US Food and Drug Administration is expected to rule on the EUA after an expert advisory committee meets to discuss the vaccine on Dec10.
Pfizer, which developed its vaccine with German partner BioNTech SE and others involved in shipping and handling of the vaccines have begun rehearsed dry-runs so that they can ensure the distribution infrastructure is functioning properly, the officials said.
States and US territories are in charge of how the coronavirus vaccine will be distributed to their populations.
The drugmakers, in concert with federal officials, will ship their vaccines to these jurisdictions, but governors are expected to determine how best to distribute it within their states.
States have developed individual plans that prioritise who will be among the first to receive vaccine doses as they become available. Many states have said they plan to vaccinate frontline healthcare workers and nursing home residents in their first push.
-
Bharat Biotech seeks trials in Bangladesh
-
What’s in Biden’s executive orders for curbing pandemic
-
Drug prevents COVID infection, maker claims
-
US to join COVID vaccine push for poor nations: Fauci
-
New virus variants may pose challenges to vaccines
-
Vaccine shipment arrives from India
-
WHO plans slew of vaccine approvals
-
Biden to hit reset on fight against COVID-19
-
India’s Bharat Biotech applies to hold COVAXIN clinical trials in Bangladesh
-
Here’s what’s in Biden’s executive orders aimed at curbing the pandemic
-
Drug prevents coronavirus infection in nursing homes, maker claims
-
US, staying in WHO, to join COVID vaccine push for poor nations: Fauci
-
Emerging coronavirus variants may pose challenges to vaccines
-
Bangladesh receives COVID-19 vaccine shipment from India
Most Read
- Can someone please open the door?
- Despite a spate of robberies, people are reluctant to use police’s ‘money escort’ service
- Miraz, Tamim guide Bangladesh to series-clinching win against West Indies
- Beximco Pharma seals deal to acquire majority stake in Sanofi Bangladesh
- Bangladesh looking for more sources to get coronavirus vaccines
- 150-foot vessel sculpture at Hudson Yards closes after 3rd suicide
- A sick couple rushed to marry on UK COVID ward. Now they have a second chance
- Google says it will shut search engine in Australia if forced to pay for news
- Drug prevents coronavirus infection in nursing homes, maker claims
- Hasina thanks Modi for sending coronavirus vaccine to Bangladesh